Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus

Lupus. 1997;6(4):415-7. doi: 10.1177/096120339700600414.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Antinuclear / analysis
  • Complement C3 / analysis
  • DNA / analysis
  • Female
  • Fluorescent Antibody Technique, Direct
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / pathology
  • Lupus Erythematosus, Systemic / therapy*
  • Middle Aged
  • Skin / immunology
  • Skin / pathology*
  • Treatment Failure

Substances

  • Antibodies, Antinuclear
  • Complement C3
  • Immunoglobulins, Intravenous
  • DNA